These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35665487)

  • 21. Human papillomavirus vaccine--opportunity and challenge.
    Baden LR; Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2007 May; 356(19):1990-1. PubMed ID: 17494932
    [No Abstract]   [Full Text] [Related]  

  • 22. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
    Lehtinen M; Gray P; Louvanto K; Vänskä S
    Expert Rev Vaccines; 2022 Jun; 21(6):735-738. PubMed ID: 35404177
    [No Abstract]   [Full Text] [Related]  

  • 23. Human papillomavirus vaccinations matter!
    van der Sande MAB; van der Loeff MFS
    Lancet Infect Dis; 2021 Oct; 21(10):1341-1342. PubMed ID: 34043962
    [No Abstract]   [Full Text] [Related]  

  • 24. Improved Education Should be provided to Healthcare Workers and to the Community to Increase Human Papillomavirus Vaccination Coverage in Adolescent Males.
    Marks K; Fassih S
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e616. PubMed ID: 34563445
    [No Abstract]   [Full Text] [Related]  

  • 25. When we increase fear, do we dampen hope? Using narrative persuasion to promote human papillomavirus vaccination in China.
    Liu S; Yang JZ; Chu H
    J Health Psychol; 2021 Sep; 26(11):1999-2009. PubMed ID: 31872781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers.
    Kacew AJ; Grimes AC; Roth M; Teoh D; Landier W; Strohbehn GW; Paskett ED
    CA Cancer J Clin; 2020 Nov; 70(6):518-519. PubMed ID: 33063840
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to The case for catch-up human papillomavirus vaccination in at-risk populations: Rural communities and survivors of pediatric and young adult cancers.
    Saslow D; Andrews KS; Manassaram-Baptiste D; Smith RA; Fontham ETH
    CA Cancer J Clin; 2020 Nov; 70(6):519-520. PubMed ID: 33063839
    [No Abstract]   [Full Text] [Related]  

  • 28. Reducing Missed Opportunities for Human Papillomavirus Vaccination in School-Based Health Centers: Impact of an Intervention.
    Shah MD; Glenn BA; Chang LC; Chung PJ; Valderrama R; Uyeda K; Szilagyi PG
    Acad Pediatr; 2020; 20(8):1124-1132. PubMed ID: 32294534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinating against HPV: A Call to Action.
    Poh A
    Cancer Discov; 2016 Mar; 6(3):222-3. PubMed ID: 26842650
    [No Abstract]   [Full Text] [Related]  

  • 30. Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study.
    Kelly MK; Grundmeier RW; Stephens-Shields AJ; Localio R; Shone LP; Wright M; Steffes J; Humiston SG; Rand C; Albertin C; Breck A; Abney DE; McFarland G; Szilagyi PG; Fiks AG
    Vaccine; 2020 Jul; 38(33):5105-5108. PubMed ID: 32540274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Papillomavirus Vaccination Status and Parental Endorsement Intentions among Undergraduate Student Nurses.
    Hollins A; Wardell D; Fernandez ME; Markham C; Guilamo-Ramos V; Santa Maria D
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33804788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [To the Editors: HPV vaccination].
    Katona G
    Orv Hetil; 2013 Jul; 154(30):1197. PubMed ID: 23876618
    [No Abstract]   [Full Text] [Related]  

  • 33. Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Rozenbaum MH; Boersma C
    J Natl Cancer Inst; 2010 Mar; 102(5):358-9; author reply 359-60. PubMed ID: 20229619
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    Coupé VM; Meijer CJ; Berkhof J
    J Natl Cancer Inst; 2010 Mar; 102(5):358; author reply 358. PubMed ID: 19861306
    [No Abstract]   [Full Text] [Related]  

  • 35. HPV vaccination does not lead to risky sexual behaviour in adolescent girls, study finds.
    McCarthy M
    BMJ; 2014 Dec; 349():g7681. PubMed ID: 25516471
    [No Abstract]   [Full Text] [Related]  

  • 36. Resolution of Harada disease-like uveitis after quadrivalent human papillomavirus vaccination: a case report.
    Kong K; Ding X; Ni Y
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-4. PubMed ID: 34348578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disentangling the Role of Religiosity in Human Papillomavirus Vaccination Amidst COVID-19 Pandemic.
    Olagoke AA; Floyd B; Caskey R; Hebert-Beirne J; Boyd AD; Molina Y
    J Relig Health; 2022 Apr; 61(2):1734-1749. PubMed ID: 35112233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 39. Do you approve of spending $300 million on HPV vaccination?: yes.
    Steben M
    Can Fam Physician; 2008 Feb; 54(2):174, 176, 178, 180. PubMed ID: 18272622
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan.
    Baussano I; Sayinzoga F; Tshomo U; Tenet V; Vorsters A; Heideman DAM; Gheit T; Tommasino M; Umulisa MC; Franceschi S; Clifford GM
    Emerg Infect Dis; 2021 Jan; 27(1):1-9. PubMed ID: 33350922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.